Klotho Neurosciences (KLTO)announced that its Letter of Intent, or LoI, with Turn Biotechnologies was allowed to expire by the parties. Following careful evaluation, Klotho’s Board of Directors ...
VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs Inc. (OTC: FITY), a leader in AI-powered healthcare and ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Carson City is now accepting Letters of Intent to Apply for our 2025-2026 Community Support Services Grant (CSSG). Carson ...
Something that should always go alongside your resume is your cover letter. Cover letters help you stand out to employers.
STEVENS POINT − Portage County took another step toward a possible sale of the Portage County Health Care Center on Sept. 16 after the County Board approved a letter of intent from a potential buyer.
LONDON / ACCESS Newswire / September 23, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has signed a Letter of Intent ("LOI") with Cellin Technologies OÜ ("Cellin"), a ...
States have until Sept. 30 to submit an optional letter of intent to the Centers for Medicare & Medicaid Services indicating ...
Artificial intelligence tools are useful, but it’s important to remember that they don’t know students and their abilities as ...
Hemogenyx Pharmaceuticals will retain full ownership of all intellectual property, know-how, data and regulatory rights relating to HG-CT-1 and will be entitled to revenues from commercialization.
NANO Nuclear Energy Inc. Signs Letter of Intent to Sell its ODIN™ Portable Low-Pressure Coolant Microreactor to Cambridge Atom Works Ltd. for $6.2 million plus future royalties. New York, N.Y., Sept.
Hemogenyx Pharmaceuticals Signs Letter of Intent with Cellin Technologies to Advance Commercialization of HG-CT-1 CAR-T Therapy in Estonia First Potential Near-Term Revenue Opportunity LONDON / ACCESS ...